Zydus Lifesci.

{
  "main_header": {
    "sid": 290229,
    "name": "Zydus Lifesci.",
    "stock_name": "Zydus Lifesci.",
    "full_name": "Zydus Lifesciences Ltd",
    "name_url": "stocks-analysis/zydus-lifesci",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "902.90",
    "chg": 23.25,
    "chgp": "2.64%",
    "dir": 1,
    "prev_price": "879.65",
    "mcapval": "90,757.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532321,
    "symbol": "ZYDUSLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE010B01027",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "10.91 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zydus-lifesci-290229-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Zydus Lifesciences Ltd Hits Intraday High with 3.05% Surge on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-hits-intraday-high-with-305-surge-on-3-feb-2026-3818483",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ZydusLifescienc_priceRelatedfactors_3818483.png",
        "date": "2026-02-03 11:36:19",
        "description": "Zydus Lifesciences Ltd demonstrated robust intraday performance on 3 February 2026, surging to an intraday high of Rs 916.75, marking a 4.26% increase from its previous close. The stock closed with a notable gain of 3.05%, outperforming the Sensex and aligning with sector momentum in Pharmaceuticals & Biotechnology."
      },
      {
        "title": "When is the next results date for Zydus Lifesciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-zydus-lifesciences-ltd-3808360",
        "imagepath": "",
        "date": "2026-01-28 23:16:16",
        "description": "The next results date for Zydus Lifesciences Ltd is scheduled for February 9, 2026...."
      },
      {
        "title": "Zydus Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-lifesciences-ltd-is-rated-sell-3804160",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZydusLifescienc_mojoScore_3804160.png",
        "date": "2026-01-25 10:10:04",
        "description": "Zydus Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Zydus Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-lifesciences-ltd-is-rated-sell-3791951",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZydusLifescienc_mojoScore_3791951.png",
        "date": "2026-01-14 10:10:04",
        "description": "Zydus Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Zydus Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zydus-lifesciences-ltd-is-rated-sell-3780074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZydusLifescienc_mojoScore_3780074.png",
        "date": "2026-01-03 10:10:05",
        "description": "Zydus Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Zydus Lifesciences Technical Momentum Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-technical-momentum-shifts-to-bearish-amid-market-underperformance-3772530",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ZydusLifescienc_technicaldot_3772530.png",
        "date": "2025-12-29 08:01:26",
        "description": "Zydus Lifesciences has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent evaluation adjustments indicate a transition towards a more cautious technical outlook, with key indicators signalling a bearish trend across multiple timeframes. This article analyses the latest price movements, technical indicators, and comparative returns to provide a comprehensive view of the stock’s current positioning."
      },
      {
        "title": "Zydus Lifesciences Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-forms-death-cross-signalling-potential-bearish-trend-3771405",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ZydusLifescienc_dealthcross_3771405.png",
        "date": "2025-12-26 18:00:30",
        "description": "Zydus Lifesciences has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock's price action over the medium to long term."
      },
      {
        "title": "Zydus Lifesciences Sees Notable Surge in Derivatives Open Interest Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-mixed-market-signals-3768290",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ZydusLifescienc_oi_spurts_by_underlying_3768290.png",
        "date": "2025-12-24 15:00:09",
        "description": "Zydus Lifesciences Ltd has registered a significant rise in open interest within its derivatives segment, reflecting evolving market positioning despite a subdued performance in the underlying equity. This development comes amid a backdrop of falling investor participation and mixed technical indicators, prompting closer scrutiny of the stock’s near-term directional bets."
      },
      {
        "title": "Zydus Lifesciences Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-mixed-market-signals-3768243",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ZydusLifescienc_oi_spurts_by_underlying_3768243.png",
        "date": "2025-12-24 14:00:09",
        "description": "Zydus Lifesciences Ltd has registered a significant rise in open interest within its derivatives segment, signalling a shift in market positioning as investors recalibrate their exposure amid subdued price movement and sectoral pressures. The pharmaceutical giant’s derivatives activity reveals evolving sentiment that may influence near-term directional trends."
      }
    ],
    "total": 588,
    "sid": "290229",
    "stock_news_url": "https://www.marketsmojo.com/news/zydus-lifesciences-290229"
  },
  "announcements": [
    {
      "details": "Cadila Healthcare Limited has informed the Exchange regarding Disclosure of Consolidated Related Party Transactions for the half year ended on September 30, 2019.",
      "source": "NSE",
      "caption": "Cadila Healthcare Limited - Other General Purpose",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 05, 2019, titled \"Zydus announces regulatory filing of Saroglitazar Magnesium for treatment of NASH with DCGI\".",
      "source": "NSE",
      "caption": "Cadila Healthcare Limited - Press Release",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Cadila Healthcare Limited has informed the Exchange regarding a press release dated December 03, 2019, titled \"Zydus receives tentative approval from the USFDA for Lorcaserin Hydrochloride Tablets\".",
      "source": "NSE",
      "caption": "Cadila Healthcare Limited - Press Release",
      "datetime": "03-Dec-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "09 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has declared <strong>1100%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:5</strong> stock split, ex-date: 06 Oct 15",
          "dt": "2015-10-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 05 Apr 10",
          "dt": "2010-04-05",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Zydus Lifesciences Ltd Hits Intraday High with 3.05% Surge on 3 Feb 2026

2026-02-03 11:36:19

Zydus Lifesciences Ltd demonstrated robust intraday performance on 3 February 2026, surging to an intraday high of Rs 916.75, marking a 4.26% increase from its previous close. The stock closed with a notable gain of 3.05%, outperforming the Sensex and aligning with sector momentum in Pharmaceuticals & Biotechnology.

Read full news article

When is the next results date for Zydus Lifesciences Ltd?

2026-01-28 23:16:16

The next results date for Zydus Lifesciences Ltd is scheduled for February 9, 2026....

Read full news article

Zydus Lifesciences Ltd is Rated Sell

2026-01-25 10:10:04

Zydus Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Zydus Lifesciences Ltd is Rated Sell

2026-01-14 10:10:04

Zydus Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Zydus Lifesciences Ltd is Rated Sell

2026-01-03 10:10:05

Zydus Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Zydus Lifesciences Technical Momentum Shifts Amid Market Volatility

2025-12-29 08:01:26

Zydus Lifesciences has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent evaluation adjustments indicate a transition towards a more cautious technical outlook, with key indicators signalling a bearish trend across multiple timeframes. This article analyses the latest price movements, technical indicators, and comparative returns to provide a comprehensive view of the stock’s current positioning.

Read full news article

Zydus Lifesciences Forms Death Cross Signalling Potential Bearish Trend

2025-12-26 18:00:30

Zydus Lifesciences has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock's price action over the medium to long term.

Read full news article

Zydus Lifesciences Sees Notable Surge in Derivatives Open Interest Amid Mixed Market Signals

2025-12-24 15:00:09

Zydus Lifesciences Ltd has registered a significant rise in open interest within its derivatives segment, reflecting evolving market positioning despite a subdued performance in the underlying equity. This development comes amid a backdrop of falling investor participation and mixed technical indicators, prompting closer scrutiny of the stock’s near-term directional bets.

Read full news article

Zydus Lifesciences Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-12-24 14:00:09

Zydus Lifesciences Ltd has registered a significant rise in open interest within its derivatives segment, signalling a shift in market positioning as investors recalibrate their exposure amid subdued price movement and sectoral pressures. The pharmaceutical giant’s derivatives activity reveals evolving sentiment that may influence near-term directional trends.

Read full news article

View All News